Glycopyrrolate Injection, Solution
Product Images NDC 0404-9782

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 0404-9782). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Formula1.jpg (Formula1)
Molecular formula: C13H23BrNO Molecular weight: 398.33 g/mol This text provides the molecular formula and the molecular weight of a compound. The molecular formula specifies the types and numbers of atoms in a molecule, while the molecular weight provides the mass of the molecule in atomic mass units.*
FDA Label Image

Image1.jpg (Image1)

Image1.jpg (Image1)
This text appears to be a scientific data table showing different parameters related to the administration of a substance (possibly a drug or chemical) in two groups: one receiving intravenous (IV) administration and another receiving intramuscular (IM) administration. The table includes values for parameters such as group, time to maximum concentration (T max), maximum concentration (C max), and area under the curve (AUC), among others. It seems to be evaluating the pharmacokinetics of the substance in the body.*
FDA Label Image

Image2.jpg (Image2)

FDA Label Image

Label1.jpg (Label1)

Label1.jpg (Label1)
This is a description for Glycopyrrolate 0.4 mg/mL Injection, USP in a 2mL Single Dose Vial for intramuscular or intravenous administration. The medication is not for use in newborns and contains benzyl alcohol. It should be kept out of children's reach and stored at a controlled room temperature between 20°C and 25°C (68°F and 77°F). The product is packaged by Henry Schein, Inc. and the manufacturer information includes NDC: 66794-203-42 by Piramal Critical Care. The prescription information and other details are also provided on the packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.